Patents Assigned to Tactogen Inc.
  • 2-AMINOINDANE COMPOUNDS FOR MENTAL DISORDERS OR ENHANCEMENT
    Publication number: 20230183199
    Abstract: The present invention discloses 2-aminoindane Formulas I and II and their pharmaceutically acceptable salts, compositions and methods of use to modulate central nervous system activity, and to treat central nervous system disorders, such as post-traumatic stress, depression, anxiety, and adjustment disorders. In certain embodiments, the compounds of the present invention can be used for entactogenic therapy in counseling sessions, as needed periodically or consistently as necessary or desired.
    Type: Application
    Filed: February 6, 2023
    Publication date: June 15, 2023
    Applicant: Tactogen Inc.
    Inventor: Matthew Baggott
  • ADVANTAGEOUS BENZOFURAN COMPOSITIONS FOR MENTAL DISORDERS OR ENHANCEMENT
    Publication number: 20230150963
    Abstract: Pharmaceutically active benzofuran compositions for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy. The present invention also includes benzofuran compounds, compositions, and methods for generally modulating central nervous system activity and treating central nervous system disorders.
    Type: Application
    Filed: December 8, 2022
    Publication date: May 18, 2023
    Applicant: Tactogen Inc.
    Inventor: Matthew Baggott